Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer
Clinical trial NCT02795819 · TERMINATED
Trial details
- NCT number
- NCT02795819
- Sponsor
- Virginia Commonwealth University
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-08
- Primary completion
- 2016-11-24
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.